An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells

Leukemia stem cells (LSCs) are thought to play a central role in the pathogenesis of acute leukemia and likely contribute to both disease initiation and relapse. Therefore, identification of agents that target LSCs is an important consideration for the development of new therapies. To this end, we h...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Guzman, Monica L., Rossi, Randall M., Neelakantan, Sundar, Li, Xiaojie, Corbett, Cheryl A., Hassane, Duane C., Becker, Michael W., Bennett, John M., Sullivan, Edmund, Lachowicz, Joshua L., Vaughan, Andrew, Sweeney, Christopher J., Matthews, William, Carroll, Martin, Liesveld, Jane L., Crooks, Peter A., Jordan, Craig T.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2007
Materias:
Neoplasia
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2234793/
https://ncbi.nlm.nih.gov/pubmed/17804695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-05-090621
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares